| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |